These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 15099287
1. Construction and characterization of a recombinant plasminogen activator composed of an anti-fibrin single-chain antibody and low-molecular-weight urokinase. Hagemeyer CE, Tomic I, Weirich U, Graeber J, Nordt T, Runge MS, Bode C, Peter K. J Thromb Haemost; 2004 May; 2(5):797-803. PubMed ID: 15099287 [Abstract] [Full Text] [Related]
2. Design and evaluation of a thrombin-activable plasminogen activator. Yang WP, Goldstein J, Procyk R, Matsueda GR, Shaw SY. Biochemistry; 1994 Mar 01; 33(8):p606-12. PubMed ID: 8117652 [Abstract] [Full Text] [Related]
8. A recombinant chimeric plasminogen activator with high affinity for fibrin has increased thrombolytic potency in vitro and in vivo. Runge MS, Quertermous T, Zavodny PJ, Love TW, Bode C, Freitag M, Shaw SY, Huang PL, Chou CC, Mullins D. Proc Natl Acad Sci U S A; 1991 Nov 15; 88(22):10337-41. PubMed ID: 1946453 [Abstract] [Full Text] [Related]
13. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding. Jiao J, Yu M, Ru B. Biochim Biophys Acta; 2001 Apr 07; 1546(2):399-405. PubMed ID: 11295444 [Abstract] [Full Text] [Related]
14. Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase. Dewerchin M, Vandamme AM, Holvoet P, De Cock F, Lemmens G, Lijnen HR, Stassen JM, Collen D. Thromb Haemost; 1992 Aug 03; 68(2):170-9. PubMed ID: 1412163 [Abstract] [Full Text] [Related]
17. Conjugation to antifibrin Fab' enhances fibrinolytic potency of single-chain urokinase plasminogen activator. Bode C, Runge MS, Schönermark S, Eberle T, Newell JB, Kübler W, Haber E. Circulation; 1990 Jun 03; 81(6):1974-80. PubMed ID: 2111744 [Abstract] [Full Text] [Related]
18. Biochemical properties of conjugates of urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin. Dewerchin M, Lijnen HR, Van Hoef B, De Cock F, Collen D. Eur J Biochem; 1989 Oct 20; 185(1):141-9. PubMed ID: 2530085 [Abstract] [Full Text] [Related]
19. Pharmacokinetic and thrombolytic properties of chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody fused to single-chain urokinase. Holvoet P, Laroche Y, Stassen JM, Lijnen HR, Van Hoef B, De Cock F, Van Houtven A, Gansemans Y, Matthyssens G, Collen D. Blood; 1993 Feb 01; 81(3):696-703. PubMed ID: 8427962 [Abstract] [Full Text] [Related]
20. Enhanced thrombolysis in plasma and in vivo by single-chain urokinase-type plasminogen activator (scuPA) conjugated to an antifibrin antibody. Bode C, Runge M, Eberle T, Freitag M, Kübler W, Haber E. Trans Assoc Am Physicians; 1989 Feb 01; 102():7-12. PubMed ID: 2517856 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]